<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32(1)</volume><submitter>Lu H</submitter><funding>Pfizer Inc</funding><pubmed_abstract>&lt;h4>Introduction&lt;/h4>The expansion of haemophilia treatment to include non-factor prophylaxis provides new options with various benefits, risks, administration modes, and device types, necessitating trade-offs in decision-making.&lt;h4>Aim&lt;/h4>This study evaluated prophylactic treatment preferences of people with haemophilia and their caregivers, assessing their willingness to make trade-offs among treatment attributes.&lt;h4>Methods&lt;/h4>A web-based survey containing a discrete-choice experiment (DCE) was completed by adults (≥ 18 years old) and caregivers of children (aged 8-17 years) with haemophilia in the United States and United Kingdom. Participants were asked to complete 10 choice tasks, choosing their preferred prophylaxis from two hypothetical profiles defined by seven attributes. The p</pubmed_abstract><journal>Haemophilia : the official journal of the World Federation of Hemophilia</journal><pagination>116-130</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12904171</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Patient and Caregiver Preferences for Long-Term Prophylactic Treatment of Bleeds in Haemophilia: A Discrete-Choice Experiment.</pubmed_title><pmcid>PMC12904171</pmcid><pubmed_authors>Whitty JA</pubmed_authors><pubmed_authors>Coulter J</pubmed_authors><pubmed_authors>Sohn A</pubmed_authors><pubmed_authors>Wilcox LJ</pubmed_authors><pubmed_authors>Christopher SA</pubmed_authors><pubmed_authors>Gutierrez-Vargas AA</pubmed_authors><pubmed_authors>Dunn N</pubmed_authors><pubmed_authors>Lu H</pubmed_authors><pubmed_authors>Colavecchia C</pubmed_authors><pubmed_authors>Hauber B</pubmed_authors><pubmed_authors>Cappelleri JC</pubmed_authors><pubmed_authors>Gould T</pubmed_authors><pubmed_authors>Chowdary P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Patient and Caregiver Preferences for Long-Term Prophylactic Treatment of Bleeds in Haemophilia: A Discrete-Choice Experiment.</name><description>&lt;h4>Introduction&lt;/h4>The expansion of haemophilia treatment to include non-factor prophylaxis provides new options with various benefits, risks, administration modes, and device types, necessitating trade-offs in decision-making.&lt;h4>Aim&lt;/h4>This study evaluated prophylactic treatment preferences of people with haemophilia and their caregivers, assessing their willingness to make trade-offs among treatment attributes.&lt;h4>Methods&lt;/h4>A web-based survey containing a discrete-choice experiment (DCE) was completed by adults (≥ 18 years old) and caregivers of children (aged 8-17 years) with haemophilia in the United States and United Kingdom. Participants were asked to complete 10 choice tasks, choosing their preferred prophylaxis from two hypothetical profiles defined by seven attributes. The p</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan-Feb</publication><modification>2026-07-09T13:20:55.546Z</modification><creation>2026-07-09T13:09:35.726Z</creation></dates><accession>S-EPMC12904171</accession><cross_references><pubmed>41358673</pubmed><doi>10.1111/hae.70172</doi></cross_references></HashMap>